Immunoprecise Antibodies Ltd
XTSX:IPA
Immunoprecise Antibodies Ltd
Net Issuance of Debt
Immunoprecise Antibodies Ltd
Net Issuance of Debt Peer Comparison
Competitive Net Issuance of Debt Analysis
Latest Figures & CAGR of Competitors
Company | Net Issuance of Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
Net Issuance of Debt
-CA$770k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Net Issuance of Debt
CA$498.7k
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
29%
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Net Issuance of Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovotech Inc
XTSX:IOT
|
Net Issuance of Debt
-CA$37.6k
|
CAGR 3-Years
19%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
See Also
What is Immunoprecise Antibodies Ltd's Net Issuance of Debt?
Net Issuance of Debt
-770k
CAD
Based on the financial report for Apr 30, 2021, Immunoprecise Antibodies Ltd's Net Issuance of Debt amounts to -770k CAD.
What is Immunoprecise Antibodies Ltd's Net Issuance of Debt growth rate?
Net Issuance of Debt CAGR 1Y
-141%
Over the last year, the Net Issuance of Debt growth was -141%.